1. Home
  2. GOSS vs SMBC Comparison

GOSS vs SMBC Comparison

Compare GOSS & SMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • SMBC
  • Stock Information
  • Founded
  • GOSS 2015
  • SMBC 1887
  • Country
  • GOSS United States
  • SMBC United States
  • Employees
  • GOSS N/A
  • SMBC N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • SMBC Banks
  • Sector
  • GOSS Health Care
  • SMBC Finance
  • Exchange
  • GOSS Nasdaq
  • SMBC Nasdaq
  • Market Cap
  • GOSS 586.6M
  • SMBC 637.0M
  • IPO Year
  • GOSS 2019
  • SMBC N/A
  • Fundamental
  • Price
  • GOSS $2.94
  • SMBC $57.36
  • Analyst Decision
  • GOSS Strong Buy
  • SMBC Hold
  • Analyst Count
  • GOSS 4
  • SMBC 3
  • Target Price
  • GOSS $8.50
  • SMBC $64.67
  • AVG Volume (30 Days)
  • GOSS 3.3M
  • SMBC 26.9K
  • Earning Date
  • GOSS 11-06-2025
  • SMBC 10-27-2025
  • Dividend Yield
  • GOSS N/A
  • SMBC 1.60%
  • EPS Growth
  • GOSS N/A
  • SMBC 8.53
  • EPS
  • GOSS N/A
  • SMBC 4.99
  • Revenue
  • GOSS $40,237,000.00
  • SMBC $172,928,000.00
  • Revenue This Year
  • GOSS N/A
  • SMBC $15.25
  • Revenue Next Year
  • GOSS $30.65
  • SMBC $9.09
  • P/E Ratio
  • GOSS N/A
  • SMBC $11.50
  • Revenue Growth
  • GOSS N/A
  • SMBC 6.00
  • 52 Week Low
  • GOSS $0.66
  • SMBC $45.10
  • 52 Week High
  • GOSS $2.98
  • SMBC $68.69
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 76.74
  • SMBC 56.65
  • Support Level
  • GOSS $2.41
  • SMBC $56.45
  • Resistance Level
  • GOSS $2.71
  • SMBC $58.24
  • Average True Range (ATR)
  • GOSS 0.19
  • SMBC 1.07
  • MACD
  • GOSS 0.04
  • SMBC 0.17
  • Stochastic Oscillator
  • GOSS 96.37
  • SMBC 68.07

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About SMBC Southern Missouri Bancorp Inc.

Southern Missouri Bancorp Inc is a USA-based holding company for Southern Missouri Savings Bank. The principal business of the bank consists of attracting retail deposits from the general public and using such deposits along with wholesale funding from the Federal Home Loan Bank of Des Moines, and to a lesser extent, brokered deposits, to invest in one- to four-family residential mortgage loans, mortgage loans secured by commercial real estate, commercial non-mortgage business loans, and consumer loans. It is engaged in providing the range of banking and financial services to individuals and corporate customers in its market areas. The company derives revenue principally from interest earned on loans, debt securities, bank card interchange fees, loan late charges and another fee income.

Share on Social Networks: